Medical Care
Global Hyperhidrosis Drugs Market Research Report 2025
- May 05, 25
- ID: 227799
- Pages: 80
- Figures: 71
- Views: 5
The global market for Hyperhidrosis Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Hyperhidrosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperhidrosis Drugs.
The Hyperhidrosis Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hyperhidrosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hyperhidrosis Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
GlaxoSmithKline
Journey Medical Corporation
Carpe
Duradry
BTXA
Seaford Pharmaceuticals
Robugen GmbH
Segment by Type
Botulinum Toxin Injections
Topical Medication
Oral Medication
Segment by Application
Primary Focal Hyperhidrosis
Secondary Generalized Hyperhidrosis
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hyperhidrosis Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Hyperhidrosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperhidrosis Drugs.
The Hyperhidrosis Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hyperhidrosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hyperhidrosis Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
GlaxoSmithKline
Journey Medical Corporation
Carpe
Duradry
BTXA
Seaford Pharmaceuticals
Robugen GmbH
Segment by Type
Botulinum Toxin Injections
Topical Medication
Oral Medication
Segment by Application
Primary Focal Hyperhidrosis
Secondary Generalized Hyperhidrosis
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hyperhidrosis Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hyperhidrosis Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Botulinum Toxin Injections
1.2.3 Topical Medication
1.2.4 Oral Medication
1.3 Market by Application
1.3.1 Global Hyperhidrosis Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Primary Focal Hyperhidrosis
1.3.3 Secondary Generalized Hyperhidrosis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hyperhidrosis Drugs Market Perspective (2020-2031)
2.2 Global Hyperhidrosis Drugs Growth Trends by Region
2.2.1 Global Hyperhidrosis Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Hyperhidrosis Drugs Historic Market Size by Region (2020-2025)
2.2.3 Hyperhidrosis Drugs Forecasted Market Size by Region (2026-2031)
2.3 Hyperhidrosis Drugs Market Dynamics
2.3.1 Hyperhidrosis Drugs Industry Trends
2.3.2 Hyperhidrosis Drugs Market Drivers
2.3.3 Hyperhidrosis Drugs Market Challenges
2.3.4 Hyperhidrosis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hyperhidrosis Drugs Players by Revenue
3.1.1 Global Top Hyperhidrosis Drugs Players by Revenue (2020-2025)
3.1.2 Global Hyperhidrosis Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Hyperhidrosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Hyperhidrosis Drugs Revenue
3.4 Global Hyperhidrosis Drugs Market Concentration Ratio
3.4.1 Global Hyperhidrosis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hyperhidrosis Drugs Revenue in 2024
3.5 Global Key Players of Hyperhidrosis Drugs Head office and Area Served
3.6 Global Key Players of Hyperhidrosis Drugs, Product and Application
3.7 Global Key Players of Hyperhidrosis Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hyperhidrosis Drugs Breakdown Data by Type
4.1 Global Hyperhidrosis Drugs Historic Market Size by Type (2020-2025)
4.2 Global Hyperhidrosis Drugs Forecasted Market Size by Type (2026-2031)
5 Hyperhidrosis Drugs Breakdown Data by Application
5.1 Global Hyperhidrosis Drugs Historic Market Size by Application (2020-2025)
5.2 Global Hyperhidrosis Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Hyperhidrosis Drugs Market Size (2020-2031)
6.2 North America Hyperhidrosis Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Hyperhidrosis Drugs Market Size by Country (2020-2025)
6.4 North America Hyperhidrosis Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hyperhidrosis Drugs Market Size (2020-2031)
7.2 Europe Hyperhidrosis Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Hyperhidrosis Drugs Market Size by Country (2020-2025)
7.4 Europe Hyperhidrosis Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hyperhidrosis Drugs Market Size (2020-2031)
8.2 Asia-Pacific Hyperhidrosis Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Hyperhidrosis Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Hyperhidrosis Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hyperhidrosis Drugs Market Size (2020-2031)
9.2 Latin America Hyperhidrosis Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Hyperhidrosis Drugs Market Size by Country (2020-2025)
9.4 Latin America Hyperhidrosis Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hyperhidrosis Drugs Market Size (2020-2031)
10.2 Middle East & Africa Hyperhidrosis Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Hyperhidrosis Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Hyperhidrosis Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Hyperhidrosis Drugs Introduction
11.1.4 Allergan Revenue in Hyperhidrosis Drugs Business (2020-2025)
11.1.5 Allergan Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Hyperhidrosis Drugs Introduction
11.2.4 GlaxoSmithKline Revenue in Hyperhidrosis Drugs Business (2020-2025)
11.2.5 GlaxoSmithKline Recent Development
11.3 Journey Medical Corporation
11.3.1 Journey Medical Corporation Company Details
11.3.2 Journey Medical Corporation Business Overview
11.3.3 Journey Medical Corporation Hyperhidrosis Drugs Introduction
11.3.4 Journey Medical Corporation Revenue in Hyperhidrosis Drugs Business (2020-2025)
11.3.5 Journey Medical Corporation Recent Development
11.4 Carpe
11.4.1 Carpe Company Details
11.4.2 Carpe Business Overview
11.4.3 Carpe Hyperhidrosis Drugs Introduction
11.4.4 Carpe Revenue in Hyperhidrosis Drugs Business (2020-2025)
11.4.5 Carpe Recent Development
11.5 Duradry
11.5.1 Duradry Company Details
11.5.2 Duradry Business Overview
11.5.3 Duradry Hyperhidrosis Drugs Introduction
11.5.4 Duradry Revenue in Hyperhidrosis Drugs Business (2020-2025)
11.5.5 Duradry Recent Development
11.6 BTXA
11.6.1 BTXA Company Details
11.6.2 BTXA Business Overview
11.6.3 BTXA Hyperhidrosis Drugs Introduction
11.6.4 BTXA Revenue in Hyperhidrosis Drugs Business (2020-2025)
11.6.5 BTXA Recent Development
11.7 Seaford Pharmaceuticals
11.7.1 Seaford Pharmaceuticals Company Details
11.7.2 Seaford Pharmaceuticals Business Overview
11.7.3 Seaford Pharmaceuticals Hyperhidrosis Drugs Introduction
11.7.4 Seaford Pharmaceuticals Revenue in Hyperhidrosis Drugs Business (2020-2025)
11.7.5 Seaford Pharmaceuticals Recent Development
11.8 Robugen GmbH
11.8.1 Robugen GmbH Company Details
11.8.2 Robugen GmbH Business Overview
11.8.3 Robugen GmbH Hyperhidrosis Drugs Introduction
11.8.4 Robugen GmbH Revenue in Hyperhidrosis Drugs Business (2020-2025)
11.8.5 Robugen GmbH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hyperhidrosis Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Botulinum Toxin Injections
1.2.3 Topical Medication
1.2.4 Oral Medication
1.3 Market by Application
1.3.1 Global Hyperhidrosis Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Primary Focal Hyperhidrosis
1.3.3 Secondary Generalized Hyperhidrosis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hyperhidrosis Drugs Market Perspective (2020-2031)
2.2 Global Hyperhidrosis Drugs Growth Trends by Region
2.2.1 Global Hyperhidrosis Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Hyperhidrosis Drugs Historic Market Size by Region (2020-2025)
2.2.3 Hyperhidrosis Drugs Forecasted Market Size by Region (2026-2031)
2.3 Hyperhidrosis Drugs Market Dynamics
2.3.1 Hyperhidrosis Drugs Industry Trends
2.3.2 Hyperhidrosis Drugs Market Drivers
2.3.3 Hyperhidrosis Drugs Market Challenges
2.3.4 Hyperhidrosis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hyperhidrosis Drugs Players by Revenue
3.1.1 Global Top Hyperhidrosis Drugs Players by Revenue (2020-2025)
3.1.2 Global Hyperhidrosis Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Hyperhidrosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Hyperhidrosis Drugs Revenue
3.4 Global Hyperhidrosis Drugs Market Concentration Ratio
3.4.1 Global Hyperhidrosis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hyperhidrosis Drugs Revenue in 2024
3.5 Global Key Players of Hyperhidrosis Drugs Head office and Area Served
3.6 Global Key Players of Hyperhidrosis Drugs, Product and Application
3.7 Global Key Players of Hyperhidrosis Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hyperhidrosis Drugs Breakdown Data by Type
4.1 Global Hyperhidrosis Drugs Historic Market Size by Type (2020-2025)
4.2 Global Hyperhidrosis Drugs Forecasted Market Size by Type (2026-2031)
5 Hyperhidrosis Drugs Breakdown Data by Application
5.1 Global Hyperhidrosis Drugs Historic Market Size by Application (2020-2025)
5.2 Global Hyperhidrosis Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Hyperhidrosis Drugs Market Size (2020-2031)
6.2 North America Hyperhidrosis Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Hyperhidrosis Drugs Market Size by Country (2020-2025)
6.4 North America Hyperhidrosis Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hyperhidrosis Drugs Market Size (2020-2031)
7.2 Europe Hyperhidrosis Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Hyperhidrosis Drugs Market Size by Country (2020-2025)
7.4 Europe Hyperhidrosis Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hyperhidrosis Drugs Market Size (2020-2031)
8.2 Asia-Pacific Hyperhidrosis Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Hyperhidrosis Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Hyperhidrosis Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hyperhidrosis Drugs Market Size (2020-2031)
9.2 Latin America Hyperhidrosis Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Hyperhidrosis Drugs Market Size by Country (2020-2025)
9.4 Latin America Hyperhidrosis Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hyperhidrosis Drugs Market Size (2020-2031)
10.2 Middle East & Africa Hyperhidrosis Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Hyperhidrosis Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Hyperhidrosis Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Hyperhidrosis Drugs Introduction
11.1.4 Allergan Revenue in Hyperhidrosis Drugs Business (2020-2025)
11.1.5 Allergan Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Hyperhidrosis Drugs Introduction
11.2.4 GlaxoSmithKline Revenue in Hyperhidrosis Drugs Business (2020-2025)
11.2.5 GlaxoSmithKline Recent Development
11.3 Journey Medical Corporation
11.3.1 Journey Medical Corporation Company Details
11.3.2 Journey Medical Corporation Business Overview
11.3.3 Journey Medical Corporation Hyperhidrosis Drugs Introduction
11.3.4 Journey Medical Corporation Revenue in Hyperhidrosis Drugs Business (2020-2025)
11.3.5 Journey Medical Corporation Recent Development
11.4 Carpe
11.4.1 Carpe Company Details
11.4.2 Carpe Business Overview
11.4.3 Carpe Hyperhidrosis Drugs Introduction
11.4.4 Carpe Revenue in Hyperhidrosis Drugs Business (2020-2025)
11.4.5 Carpe Recent Development
11.5 Duradry
11.5.1 Duradry Company Details
11.5.2 Duradry Business Overview
11.5.3 Duradry Hyperhidrosis Drugs Introduction
11.5.4 Duradry Revenue in Hyperhidrosis Drugs Business (2020-2025)
11.5.5 Duradry Recent Development
11.6 BTXA
11.6.1 BTXA Company Details
11.6.2 BTXA Business Overview
11.6.3 BTXA Hyperhidrosis Drugs Introduction
11.6.4 BTXA Revenue in Hyperhidrosis Drugs Business (2020-2025)
11.6.5 BTXA Recent Development
11.7 Seaford Pharmaceuticals
11.7.1 Seaford Pharmaceuticals Company Details
11.7.2 Seaford Pharmaceuticals Business Overview
11.7.3 Seaford Pharmaceuticals Hyperhidrosis Drugs Introduction
11.7.4 Seaford Pharmaceuticals Revenue in Hyperhidrosis Drugs Business (2020-2025)
11.7.5 Seaford Pharmaceuticals Recent Development
11.8 Robugen GmbH
11.8.1 Robugen GmbH Company Details
11.8.2 Robugen GmbH Business Overview
11.8.3 Robugen GmbH Hyperhidrosis Drugs Introduction
11.8.4 Robugen GmbH Revenue in Hyperhidrosis Drugs Business (2020-2025)
11.8.5 Robugen GmbH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Hyperhidrosis Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Botulinum Toxin Injections
Table 3. Key Players of Topical Medication
Table 4. Key Players of Oral Medication
Table 5. Global Hyperhidrosis Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Hyperhidrosis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Hyperhidrosis Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Hyperhidrosis Drugs Market Share by Region (2020-2025)
Table 9. Global Hyperhidrosis Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Hyperhidrosis Drugs Market Share by Region (2026-2031)
Table 11. Hyperhidrosis Drugs Market Trends
Table 12. Hyperhidrosis Drugs Market Drivers
Table 13. Hyperhidrosis Drugs Market Challenges
Table 14. Hyperhidrosis Drugs Market Restraints
Table 15. Global Hyperhidrosis Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Hyperhidrosis Drugs Market Share by Players (2020-2025)
Table 17. Global Top Hyperhidrosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperhidrosis Drugs as of 2024)
Table 18. Ranking of Global Top Hyperhidrosis Drugs Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Hyperhidrosis Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Hyperhidrosis Drugs, Headquarters and Area Served
Table 21. Global Key Players of Hyperhidrosis Drugs, Product and Application
Table 22. Global Key Players of Hyperhidrosis Drugs, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hyperhidrosis Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Hyperhidrosis Drugs Revenue Market Share by Type (2020-2025)
Table 26. Global Hyperhidrosis Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Hyperhidrosis Drugs Revenue Market Share by Type (2026-2031)
Table 28. Global Hyperhidrosis Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Hyperhidrosis Drugs Revenue Market Share by Application (2020-2025)
Table 30. Global Hyperhidrosis Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Hyperhidrosis Drugs Revenue Market Share by Application (2026-2031)
Table 32. North America Hyperhidrosis Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Hyperhidrosis Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Hyperhidrosis Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Hyperhidrosis Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Hyperhidrosis Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Hyperhidrosis Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Hyperhidrosis Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Hyperhidrosis Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Hyperhidrosis Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Hyperhidrosis Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Hyperhidrosis Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Hyperhidrosis Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Hyperhidrosis Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Hyperhidrosis Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Hyperhidrosis Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 47. Allergan Company Details
Table 48. Allergan Business Overview
Table 49. Allergan Hyperhidrosis Drugs Product
Table 50. Allergan Revenue in Hyperhidrosis Drugs Business (2020-2025) & (US$ Million)
Table 51. Allergan Recent Development
Table 52. GlaxoSmithKline Company Details
Table 53. GlaxoSmithKline Business Overview
Table 54. GlaxoSmithKline Hyperhidrosis Drugs Product
Table 55. GlaxoSmithKline Revenue in Hyperhidrosis Drugs Business (2020-2025) & (US$ Million)
Table 56. GlaxoSmithKline Recent Development
Table 57. Journey Medical Corporation Company Details
Table 58. Journey Medical Corporation Business Overview
Table 59. Journey Medical Corporation Hyperhidrosis Drugs Product
Table 60. Journey Medical Corporation Revenue in Hyperhidrosis Drugs Business (2020-2025) & (US$ Million)
Table 61. Journey Medical Corporation Recent Development
Table 62. Carpe Company Details
Table 63. Carpe Business Overview
Table 64. Carpe Hyperhidrosis Drugs Product
Table 65. Carpe Revenue in Hyperhidrosis Drugs Business (2020-2025) & (US$ Million)
Table 66. Carpe Recent Development
Table 67. Duradry Company Details
Table 68. Duradry Business Overview
Table 69. Duradry Hyperhidrosis Drugs Product
Table 70. Duradry Revenue in Hyperhidrosis Drugs Business (2020-2025) & (US$ Million)
Table 71. Duradry Recent Development
Table 72. BTXA Company Details
Table 73. BTXA Business Overview
Table 74. BTXA Hyperhidrosis Drugs Product
Table 75. BTXA Revenue in Hyperhidrosis Drugs Business (2020-2025) & (US$ Million)
Table 76. BTXA Recent Development
Table 77. Seaford Pharmaceuticals Company Details
Table 78. Seaford Pharmaceuticals Business Overview
Table 79. Seaford Pharmaceuticals Hyperhidrosis Drugs Product
Table 80. Seaford Pharmaceuticals Revenue in Hyperhidrosis Drugs Business (2020-2025) & (US$ Million)
Table 81. Seaford Pharmaceuticals Recent Development
Table 82. Robugen GmbH Company Details
Table 83. Robugen GmbH Business Overview
Table 84. Robugen GmbH Hyperhidrosis Drugs Product
Table 85. Robugen GmbH Revenue in Hyperhidrosis Drugs Business (2020-2025) & (US$ Million)
Table 86. Robugen GmbH Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
Table 90. Authors List of This Report
List of Figures
Figure 1. Hyperhidrosis Drugs Picture
Figure 2. Global Hyperhidrosis Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hyperhidrosis Drugs Market Share by Type: 2024 VS 2031
Figure 4. Botulinum Toxin Injections Features
Figure 5. Topical Medication Features
Figure 6. Oral Medication Features
Figure 7. Global Hyperhidrosis Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Hyperhidrosis Drugs Market Share by Application: 2024 VS 2031
Figure 9. Primary Focal Hyperhidrosis Case Studies
Figure 10. Secondary Generalized Hyperhidrosis Case Studies
Figure 11. Hyperhidrosis Drugs Report Years Considered
Figure 12. Global Hyperhidrosis Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Hyperhidrosis Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Hyperhidrosis Drugs Market Share by Region: 2024 VS 2031
Figure 15. Global Hyperhidrosis Drugs Market Share by Players in 2024
Figure 16. Global Top Hyperhidrosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperhidrosis Drugs as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Hyperhidrosis Drugs Revenue in 2024
Figure 18. North America Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Hyperhidrosis Drugs Market Share by Country (2020-2031)
Figure 20. United States Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Hyperhidrosis Drugs Market Share by Country (2020-2031)
Figure 24. Germany Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Hyperhidrosis Drugs Market Share by Region (2020-2031)
Figure 32. China Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Hyperhidrosis Drugs Market Share by Country (2020-2031)
Figure 40. Mexico Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Hyperhidrosis Drugs Market Share by Country (2020-2031)
Figure 44. Turkey Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Allergan Revenue Growth Rate in Hyperhidrosis Drugs Business (2020-2025)
Figure 48. GlaxoSmithKline Revenue Growth Rate in Hyperhidrosis Drugs Business (2020-2025)
Figure 49. Journey Medical Corporation Revenue Growth Rate in Hyperhidrosis Drugs Business (2020-2025)
Figure 50. Carpe Revenue Growth Rate in Hyperhidrosis Drugs Business (2020-2025)
Figure 51. Duradry Revenue Growth Rate in Hyperhidrosis Drugs Business (2020-2025)
Figure 52. BTXA Revenue Growth Rate in Hyperhidrosis Drugs Business (2020-2025)
Figure 53. Seaford Pharmaceuticals Revenue Growth Rate in Hyperhidrosis Drugs Business (2020-2025)
Figure 54. Robugen GmbH Revenue Growth Rate in Hyperhidrosis Drugs Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Table 1. Global Hyperhidrosis Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Botulinum Toxin Injections
Table 3. Key Players of Topical Medication
Table 4. Key Players of Oral Medication
Table 5. Global Hyperhidrosis Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Hyperhidrosis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Hyperhidrosis Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Hyperhidrosis Drugs Market Share by Region (2020-2025)
Table 9. Global Hyperhidrosis Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Hyperhidrosis Drugs Market Share by Region (2026-2031)
Table 11. Hyperhidrosis Drugs Market Trends
Table 12. Hyperhidrosis Drugs Market Drivers
Table 13. Hyperhidrosis Drugs Market Challenges
Table 14. Hyperhidrosis Drugs Market Restraints
Table 15. Global Hyperhidrosis Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Hyperhidrosis Drugs Market Share by Players (2020-2025)
Table 17. Global Top Hyperhidrosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperhidrosis Drugs as of 2024)
Table 18. Ranking of Global Top Hyperhidrosis Drugs Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Hyperhidrosis Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Hyperhidrosis Drugs, Headquarters and Area Served
Table 21. Global Key Players of Hyperhidrosis Drugs, Product and Application
Table 22. Global Key Players of Hyperhidrosis Drugs, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hyperhidrosis Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Hyperhidrosis Drugs Revenue Market Share by Type (2020-2025)
Table 26. Global Hyperhidrosis Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Hyperhidrosis Drugs Revenue Market Share by Type (2026-2031)
Table 28. Global Hyperhidrosis Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Hyperhidrosis Drugs Revenue Market Share by Application (2020-2025)
Table 30. Global Hyperhidrosis Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Hyperhidrosis Drugs Revenue Market Share by Application (2026-2031)
Table 32. North America Hyperhidrosis Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Hyperhidrosis Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Hyperhidrosis Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Hyperhidrosis Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Hyperhidrosis Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Hyperhidrosis Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Hyperhidrosis Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Hyperhidrosis Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Hyperhidrosis Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Hyperhidrosis Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Hyperhidrosis Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Hyperhidrosis Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Hyperhidrosis Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Hyperhidrosis Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Hyperhidrosis Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 47. Allergan Company Details
Table 48. Allergan Business Overview
Table 49. Allergan Hyperhidrosis Drugs Product
Table 50. Allergan Revenue in Hyperhidrosis Drugs Business (2020-2025) & (US$ Million)
Table 51. Allergan Recent Development
Table 52. GlaxoSmithKline Company Details
Table 53. GlaxoSmithKline Business Overview
Table 54. GlaxoSmithKline Hyperhidrosis Drugs Product
Table 55. GlaxoSmithKline Revenue in Hyperhidrosis Drugs Business (2020-2025) & (US$ Million)
Table 56. GlaxoSmithKline Recent Development
Table 57. Journey Medical Corporation Company Details
Table 58. Journey Medical Corporation Business Overview
Table 59. Journey Medical Corporation Hyperhidrosis Drugs Product
Table 60. Journey Medical Corporation Revenue in Hyperhidrosis Drugs Business (2020-2025) & (US$ Million)
Table 61. Journey Medical Corporation Recent Development
Table 62. Carpe Company Details
Table 63. Carpe Business Overview
Table 64. Carpe Hyperhidrosis Drugs Product
Table 65. Carpe Revenue in Hyperhidrosis Drugs Business (2020-2025) & (US$ Million)
Table 66. Carpe Recent Development
Table 67. Duradry Company Details
Table 68. Duradry Business Overview
Table 69. Duradry Hyperhidrosis Drugs Product
Table 70. Duradry Revenue in Hyperhidrosis Drugs Business (2020-2025) & (US$ Million)
Table 71. Duradry Recent Development
Table 72. BTXA Company Details
Table 73. BTXA Business Overview
Table 74. BTXA Hyperhidrosis Drugs Product
Table 75. BTXA Revenue in Hyperhidrosis Drugs Business (2020-2025) & (US$ Million)
Table 76. BTXA Recent Development
Table 77. Seaford Pharmaceuticals Company Details
Table 78. Seaford Pharmaceuticals Business Overview
Table 79. Seaford Pharmaceuticals Hyperhidrosis Drugs Product
Table 80. Seaford Pharmaceuticals Revenue in Hyperhidrosis Drugs Business (2020-2025) & (US$ Million)
Table 81. Seaford Pharmaceuticals Recent Development
Table 82. Robugen GmbH Company Details
Table 83. Robugen GmbH Business Overview
Table 84. Robugen GmbH Hyperhidrosis Drugs Product
Table 85. Robugen GmbH Revenue in Hyperhidrosis Drugs Business (2020-2025) & (US$ Million)
Table 86. Robugen GmbH Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
Table 90. Authors List of This Report
List of Figures
Figure 1. Hyperhidrosis Drugs Picture
Figure 2. Global Hyperhidrosis Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hyperhidrosis Drugs Market Share by Type: 2024 VS 2031
Figure 4. Botulinum Toxin Injections Features
Figure 5. Topical Medication Features
Figure 6. Oral Medication Features
Figure 7. Global Hyperhidrosis Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Hyperhidrosis Drugs Market Share by Application: 2024 VS 2031
Figure 9. Primary Focal Hyperhidrosis Case Studies
Figure 10. Secondary Generalized Hyperhidrosis Case Studies
Figure 11. Hyperhidrosis Drugs Report Years Considered
Figure 12. Global Hyperhidrosis Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Hyperhidrosis Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Hyperhidrosis Drugs Market Share by Region: 2024 VS 2031
Figure 15. Global Hyperhidrosis Drugs Market Share by Players in 2024
Figure 16. Global Top Hyperhidrosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperhidrosis Drugs as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Hyperhidrosis Drugs Revenue in 2024
Figure 18. North America Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Hyperhidrosis Drugs Market Share by Country (2020-2031)
Figure 20. United States Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Hyperhidrosis Drugs Market Share by Country (2020-2031)
Figure 24. Germany Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Hyperhidrosis Drugs Market Share by Region (2020-2031)
Figure 32. China Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Hyperhidrosis Drugs Market Share by Country (2020-2031)
Figure 40. Mexico Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Hyperhidrosis Drugs Market Share by Country (2020-2031)
Figure 44. Turkey Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Hyperhidrosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Allergan Revenue Growth Rate in Hyperhidrosis Drugs Business (2020-2025)
Figure 48. GlaxoSmithKline Revenue Growth Rate in Hyperhidrosis Drugs Business (2020-2025)
Figure 49. Journey Medical Corporation Revenue Growth Rate in Hyperhidrosis Drugs Business (2020-2025)
Figure 50. Carpe Revenue Growth Rate in Hyperhidrosis Drugs Business (2020-2025)
Figure 51. Duradry Revenue Growth Rate in Hyperhidrosis Drugs Business (2020-2025)
Figure 52. BTXA Revenue Growth Rate in Hyperhidrosis Drugs Business (2020-2025)
Figure 53. Seaford Pharmaceuticals Revenue Growth Rate in Hyperhidrosis Drugs Business (2020-2025)
Figure 54. Robugen GmbH Revenue Growth Rate in Hyperhidrosis Drugs Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Advanced Enteric Capsules Market Research Report 2025
Jul 08, 25
Global Outdoor Structures and Chairs Market Research Report 2025
Jul 08, 25
Global Herbs Ingredients Market Research Report 2025
Jul 08, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232